Literature DB >> 16392817

Discovery of benzylidenebenzofuran-3(2H)-one (aurones) as inhibitors of tyrosinase derived from human melanocytes.

Sabrina Okombi1, Delphine Rival, Sébastien Bonnet, Anne-Marie Mariotte, Eric Perrier, Ahcène Boumendjel.   

Abstract

Tyrosinase is a copper-dependent enzyme which converts l- tyrosine to dopaquinone and is involved in different biological processes such as melanogenesis and skin hyperpigmentation. The purpose of this study was to investigate naturally occurring aurones (Z-benzylidenebenzofuran-3(2H)-one) and analogues as human tyrosinase inhibitors. Several aurones bearing hydroxyl groups on A-ring and different substituents on B-ring were synthesized and evaluated as inhibitors of human melanocyte-tyrosinase by an assay which measures tyrosinase-catalyzed l-Dopa oxidation. We found that unsubstituted aurones were weak inhibitors; however, derivatives with two or three hydroxyl groups preferably at 4,6 and 4' positions are able to induce significant tyrosinase inhibition. The most potent aurone was found to be the naturally occurring 4,6,4'-trihydroxyaurone which induces 75% inhibition at 0.1 mM concentration and is highly effective when compared to kojic acid, one of the best tyrosinase inhibitors known so far (the latter is completely inactive at such concentrations). Active aurones are devoid of toxic effects as shown by in vivo studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16392817     DOI: 10.1021/jm050715i

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  Bond-based 2D TOMOCOMD-CARDD approach for drug discovery: aiding decision-making in 'in silico' selection of new lead tyrosinase inhibitors.

Authors:  Yovani Marrero-Ponce; Mahmud Tareq Hassan Khan; Gerardo M Casañola-Martín; Arjumand Ather; Mukhlis N Sultankhodzhaev; Ramón García-Domenech; Francisco Torrens; Richard Rotondo
Journal:  J Comput Aided Mol Des       Date:  2007-02-28       Impact factor: 3.686

Review 2.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

3.  2-Hydroxypyridine-N-oxide-Embedded Aurones as Potent Human Tyrosinase Inhibitors.

Authors:  Romain Haudecoeur; Marcello Carotti; Aurélie Gouron; Marc Maresca; Elina Buitrago; Renaud Hardré; Elisabetta Bergantino; Hélène Jamet; Catherine Belle; Marius Réglier; Luigi Bubacco; Ahcène Boumendjel
Journal:  ACS Med Chem Lett       Date:  2016-11-17       Impact factor: 4.345

4.  Discovery of naturally occurring aurones that are potent allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase.

Authors:  Romain Haudecoeur; Abdelhakim Ahmed-Belkacem; Wei Yi; Antoine Fortuné; Rozenn Brillet; Catherine Belle; Edwige Nicolle; Coralie Pallier; Jean-Michel Pawlotsky; Ahcène Boumendjel
Journal:  J Med Chem       Date:  2011-07-06       Impact factor: 7.446

5.  (Z)-2-(2-Hy-droxy-4-meth-oxy-benzyl-idene)-1-benzofuran-3(2H)-one.

Authors:  J Satyanarayana Reddy; N Ravi Kumar; J Venkata Prasad; G Gopikrishna; K Anand Solomon
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-05-07

Review 6.  Gold-catalyzed cyclizations of alkynol-based compounds: synthesis of natural products and derivatives.

Authors:  Benito Alcaide; Pedro Almendros; José M Alonso
Journal:  Molecules       Date:  2011-09-13       Impact factor: 4.411

Review 7.  A comprehensive review on tyrosinase inhibitors.

Authors:  Samaneh Zolghadri; Asieh Bahrami; Mahmud Tareq Hassan Khan; J Munoz-Munoz; F Garcia-Molina; F Garcia-Canovas; Ali Akbar Saboury
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

8.  Anti-Melanogenic Properties of Velutin and Its Analogs.

Authors:  Se-Hui Jung; Hee-Young Heo; Jung-Won Choe; Jaehyun Kim; Kooyeon Lee
Journal:  Molecules       Date:  2021-05-19       Impact factor: 4.411

9.  ArCH(OMe)₂--a Pt(IV)-catalyst originator for diverse annulation catalysis.

Authors:  Subhadeep Ghosh; Saikat Khamarui; Krishnanka S Gayen; Dilip K Maiti
Journal:  Sci Rep       Date:  2013-10-18       Impact factor: 4.379

10.  New chroman-4-one/thiochroman-4-one derivatives as potential anticancer agents.

Authors:  Seref Demirayak; Leyla Yurttas; Nalan Gundogdu-Karaburun; Ahmet Cagri Karaburun; Ismail Kayagil
Journal:  Saudi Pharm J       Date:  2017-04-26       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.